1
|
Karam M, Alsaif A, Al-Naseem A, Hayre A, Al Jabbouri A, Aldubaikhi A, Kahlar N, Al-Mutairi S. Mycophenolate versus Methotrexate in Non-infectious Ocular Inflammatory Disease: A Systematic Review and Meta-Analysis. Ocul Immunol Inflamm 2022; 31:613-620. [PMID: 35201968 DOI: 10.1080/09273948.2022.2034166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
PURPOSE To compare the outcomes of mycophenolate mofetil (MMF) versus methotrexate (MTX) in non-infectious ocular inflammatory disease (NIOID). METHODS The study was performed as per the PRISMA Guidelines. A search identified all studies comparing MMF versus MTX in NIOID. Treatment result and side effects were primary outcomes. RESULTS Four studies enrolling 905 patients were identified. There was no significant difference between MMF and MTX groups in overall treatment success (OR = 0.97, P = .96), treatment failure (OR = 0.86, P = .85). MTX showed a significantly improved effect in cases involving posterior uveitis and panuveitis (OR = 0.41, P = .003). In addition, MTX was associated with a faster median time to treatment success and had less side effects when compared to MTX, however this was not significant. For secondary outcomes, no significant difference was found in visual acuity and resolution of macular oedema. CONCLUSION MMF is comparable to MTX in the treatment of NIOID.
Collapse
Affiliation(s)
- Mohammad Karam
- Bachelor of Medicine and Bachelor of Surgery (MBChB), School of Medicine, University of Leeds, Leeds, UK.,Farwaniya Hospital, Ministry of Health, State of Kuwait
| | - Abdulmalik Alsaif
- Bachelor of Medicine and Bachelor of Surgery (MBChB), School of Medicine, University of Leeds, Leeds, UK.,West Midlands, West Midlands, UK
| | | | - Amrit Hayre
- Bachelor of Medicine and Bachelor of Surgery (MBChB), School of Medicine, University of Leeds, Leeds, UK.,Whittington Health NHS Trust, London, UK
| | | | - Ahmed Aldubaikhi
- Bachelor of Medicine and Surgery (MBBS), College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Narvair Kahlar
- Bachelor of Medicine and Bachelor of Surgery (MBChB), School of Medicine, University of Leeds, Leeds, UK.,Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, UK
| | - Salem Al-Mutairi
- Senior Consultant Ophthalmic Surgeon (M.D, FRCSC, External Eye Diseases, Cornea, Refractive Surgery and Uveitis), Head of Uveitis Unit, Al-Bahar Eye Center, Ministry of Health of Kuwait, State of Kuwait.,Program Director of Kuwait Board of Ophthalmology, Kuwait Institute of Medical Specialities (KIMS), State of Kuwait
| |
Collapse
|